Ignite Creation Date:
2024-05-05 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 9:55 AM
Study NCT ID:
NCT00758043
Status:
COMPLETED
Last Update Posted:
2021-03-26
First Post:
2008-09-19
Brief Title:
A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Organization Data
Organization:
Vertex Pharmaceuticals Incorporated
Class:
INDUSTRY
Study ID:
VX08-950-111
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vertex Pharmaceuticals Incorporated
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Tibotec Pharmaceutical Limited | INDUSTRY |